Bellerophon Therapeutics Inc
NASDAQ:BLPH 11:10:31 AM EDT
Earnings Announcements
Bellerophon Provides Clinical Program Update And Reports First Quarter 2022 Financial Results
Published: 05/11/2022 12:38 GMT
Bellerophon Therapeutics Inc (BLPH) - Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.59.
Q1 Loss per Share $0.59.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.61
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.61
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56
More details on our Analysts Page.